Companies: 10,795·Total market cap: $144.5T
Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SIONNASDAQHealthcare● Active
$33.51
$-1.86(-5.26%)
Market Cap$1.5B
P/E Ratio
52W High$48.445
52W Low$13.51
Overview

Sionna Therapeutics, Inc. (SION) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · SION · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.06B$0.06B$0.04B$0.03B
G&A Expenses$0.03B$0.01B$0.01B$0.01B
Total Operating Expenses$0.09B$0.07B$0.05B$0.04B
Operating Income($0.09B)($0.07B)($0.05B)($0.04B)
Operating Margin %(computed)
Interest Income$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.08B)($0.06B)($0.05B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B
Net Income($0.08B)($0.06B)($0.05B)($0.04B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.88$-1.40$-1.07$-0.91
Wtd Avg Shares0.04B0.04B0.04B0.04B
EBITDA($0.09B)($0.07B)($0.05B)($0.04B)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Sionna Therapeutics, Inc. data

About Sionna Therapeutics, Inc. (SION) Income Statement

Sionna Therapeutics, Inc. (SION) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SION reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.08B) — a net profit margin of —.

Frequently asked questions

SION · 4 questions

Sionna Therapeutics, Inc. (SION) reported revenue of $0.00B for 2025, down —% year-over-year.

SION revenueSION salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08